Vadrevu K. Raju
West Virginia University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Vadrevu K. Raju.
British Journal of Ophthalmology | 2005
Ying-Ying Gao; M. A. Di Pascuale; Wei Li; Alireza Baradaran-Rafii; Antonio Elizondo; C.L. Kuo; Vadrevu K. Raju; Scheffer C. G. Tseng
Aims: To compare the in vitro killing effect of different agents on Demodex and to report the in vivo killing effect of tea tree oil (TTO) on ocular Demodex. Methods: Survival time of Demodex was measured under the microscope. Sampling and counting of Demodex was performed by a modified method. Results: Demodex folliculorum survived for more than 150 minutes in 10% povidone-iodine, 75% alcohol, 50% baby shampoo, and 4% pilocarpine. However, the survival time was significantly shortened to within 15 minutes in 100% alcohol, 100% TTO, 100% caraway oil, or 100% dill weed oil. TTO’s in vitro killing effect was dose dependent. Lid scrub with 50% TTO, but not with 50% baby shampoo, can further stimulate Demodex to move out to the skin. The Demodex count did not reach zero in any of the seven patients receiving daily lid scrub with baby shampoo for 40–350 days. In contrast, the Demodex count dropped to zero in seven of nine patients receiving TTO scrub in 4 weeks without recurrence. Conclusions: Demodex is resistant to a wide range of antiseptic solutions. Weekly lid scrub with 50% TTO and daily lid scrub with tea tree shampoo is effective in eradicating ocular Demodex.
Ophthalmology | 2010
Jianjing Li; Niamh O'Reilly; Hosam Sheha; Raananah Katz; Vadrevu K. Raju; Kevin Kavanagh; Scheffer C. G. Tseng
PURPOSE To investigate correlation between ocular Demodex infestation and serum. DESIGN A prospective study to correlate clinical findings with laboratory data. PARTICIPANTS We consecutively enrolled 59 patients: 34 men and 25 women with a mean age of 60.4+/-17.6 years (range, 17-93). METHODS Demodex counting was performed based on lash sampling. Serum immunoreactivity to two 62-kDa and 83-kDa proteins derived from B oleronius was determined by Western blot analysis. Facial rosacea, lid margin, and ocular surface inflammation were documented by photography and graded in a masked fashion. MAIN OUTCOME MEASURES Statistical significance based on correlative analyses of clinical and laboratory data. RESULTS These 59 patients were age matched, but not gender matched, regarding serum immunoreactivity, ocular Demodex infestation, or facial rosacea. There was a significant correlation between serum immunoreactivity and facial rosacea (P = 0.009), lid margin inflammation (P = 0.040), and ocular Demodex infestation (P = 0.048), but not inferior bulbar conjunctival inflammation (P = 0.573). The Demodex count was significantly higher in patients with positive facial rosacea (6.6+/-9.0 vs. 1.9+/-2.2; P = 0.014). There was a significant correlation of facial rosacea with lid margin inflammation (P = 0.016), but not with inferior bulbar conjunctival inflammation (P = 0.728). Ocular Demodex infestation was less prevalent in patients with aqueous tear-deficiency dry eye than those without (7/38 vs. 12/21; P = 0.002). CONCLUSIONS The strong correlation provides a better understanding of comorbidity between Demodex mites and their symbiotic B oleronius in facial rosacea and blepharitis. Treatments directed to both warrant future investigation.
Cornea | 2010
Lingyi Liang; Steve Safran; Ying-Ying Gao; Hosam Sheha; Vadrevu K. Raju; Scheffer C. G. Tseng
Purpose: To report Demodex infestation in pediatric blepharoconjunctivitis. Methods: A retrospective review of 12 patients, with ages from 2.5-11 years, with chronic blepharoconjunctivitis who failed to respond to conventional treatments. Demodex was detected by lash sampling and microscopic examination. Patients were treated with 50% tea tree oil (TTO) eyelid scrubs or 5% TTO ointment eyelid massages for 4-6 weeks. Results: Demodex mites were found in all, but 1 case had cylindrical dandruff in the lashes. After 1 week of TTO treatment, all patients showed dramatic resolution of ocular irritation and inflammation while Demodex counts dropped. All corneal signs resolved within 2 weeks except for a residual anterior stromal scar in 1 eye. During a follow-up period of 8.3 ± 4.6 months, 1 patient showed recurrent inflammation, which was successfully managed by a second round of TTO treatment. Conclusions: Demodicosis should be considered as a potential cause of pediatric refractory blepharoconjunctivitis. Eyelid scrubs or massage with TTO could be an effective treatment regimen in these cases.
Ophthalmology | 1986
Ivan R. Schwab; Vadrevu K. Raju; James E. McClung
Indirect immunofluorescent techniques were used to diagnose active herpes simplex virus ocular infections in 84 patient observations (41 with ocular lesions suspicious clinically for herpes simplex and 43 with lesions suspicious clinically for other ocular inflammatory conditions). We found indirect immunofluorescent antibody techniques to have a high sensitivity (97%) and specificity (73%) when compared to herpes simplex virus cultures. Similarly, we found the sensitivity (98%) and specificity (77%) of indirect immunofluorescent antibody techniques to be high when compared to the clinical diagnosis of herpes simplex viral infection. Significantly, there were no false negative tests by indirect immunofluorescent techniques. Both corneal and upper tarsal scrapings by indirect immunofluorescence were used and the upper tarsal scrapings were an excellent source of cells exhibiting herpes simplex virus antigens. All cases in which corneal scrapings were positive by indirect immunofluorescence for herpes simplex ere also positive by upper tarsal scrapings, although the converse was not true.
Ophthalmology | 2005
Mario A. Di Pascuale; Edgar M. Espana; Daniel Tzong-Shyue Liu; Tetsuya Kawakita; Wei Li; Ying Y. Gao; Alireza Baradaran-Rafii; Antonio Elizondo; Vadrevu K. Raju; Scheffer C. G. Tseng
Investigative Ophthalmology & Visual Science | 2003
Edgar M. Espana; Hua He; Tetsuya Kawakita; Mario A. Di Pascuale; Vadrevu K. Raju; Chia-Yang Liu; Scheffer C. G. Tseng
Investigative Ophthalmology & Visual Science | 2005
Ying-Ying Gao; Mario A. Di Pascuale; Wei Li; Daniel Tzong-Shyue Liu; Alireza Baradaran-Rafii; Antonio Elizondo; Tetsuya Kawakita; Vadrevu K. Raju; Scheffer C. G. Tseng
Investigative Ophthalmology & Visual Science | 2004
Edgar M. Espana; Mario A. Di Pascuale; Hua He; Tetsuya Kawakita; Vadrevu K. Raju; Chia-Yang Liu; Scheffer C. G. Tseng
Investigative Ophthalmology & Visual Science | 2016
Ahmad Kheirkhah; Vadrevu K. Raju; Pedram Hamrah; Reza Dana
Investigative Ophthalmology & Visual Science | 2008
Lingyi Liang; Ahmad Kheirkhah; Vadrevu K. Raju; Scheffer C. G. Tseng